Addyi (flibanserin) — Point32Health
Acquired, generalized hypoactive sexual desire disorder (HSDD) characterized by low sexual desire causing marked distress or interpersonal difficulty
Initial criteria
- Diagnosis of acquired, generalized hypoactive sexual desire disorder characterized by low sexual desire AND
- Diagnosis is not due to a co-existing medical or psychiatric condition, problems with the relationship, or the effects of a medication or other drug substance have been addressed AND
- Patient is premenopausal
Reauthorization criteria
- Documentation that the patient continues to meet all coverage criteria
Approval duration
Addyi: 1 year initial, 1 year subsequent; Vyleesi: 8 weeks initial, 1 year subsequent